期刊
EUROPEAN JOURNAL OF MEDICAL RESEARCH
卷 26, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s40001-021-00490-1
关键词
COVID-19; SARS-COV-2; 2019-nCoV; Vitamin C; Pneumonia; Hydroxychloroquine; Lopinavir; Ritonavir
资金
- Tehran University of Medical Sciences (TUMS) [99-1-101-47277]
The study found that there were no significantly better outcomes at discharge in patients with severe COVID-19 who received high-dose intravenous vitamin C (HDIVC) in addition to the main treatment regimen.
Background Vitamin C is an essential water-soluble nutrient that functions as a key antioxidant and has been proven to be effective for boosting immunity. In this study, we aimed to assess the efficacy of adding high-dose intravenous vitamin C (HDIVC) to the regimens for patients with severe COVID-19 disease. Methods An open-label, randomized, and controlled trial was conducted on patients with severe COVID-19 infection. The case and control treatment groups each consisted of 30 patients. The control group received lopinavir/ritonavir and hydroxychloroquine and the case group received HDIVC (6 g daily) added to the same regimen. Results There were no statistically significant differences between two groups with respect to age and gender, laboratory results, and underlying diseases. The mean body temperature was significantly lower in the case group on the 3rd day of hospitalization (p = 0.001). Peripheral capillary oxygen saturations (SpO(2)) measured at the 3rd day of hospitalization was also higher in the case group receiving HDIVC (p = 0.014). The median length of hospitalization in the case group was significantly longer than the control group (8.5 days vs. 6.5 days) (p = 0.028). There was no significant difference in SpO(2) levels at discharge time, the length of intensive care unit (ICU) stay, and mortality between the two groups. Conclusions We did not find significantly better outcomes in the group who were treated with HDIVC in addition to the main treatment regimen at discharge. Trial registration irct.ir (IRCT20200411047025N1), April 14, 2020
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据